Skip To The Main Content
2023 PDA_Training-1988x680

PDA EU00007 Extractables and Leachables

Apr 25 - Apr 26, 2024
Copenhagen, Denmark

Including: Important Regulatory Updates – Case Study Section: Selection of Nelson Labs’ most interesting Case Studies, presented over the last 10 years!

  • Education
  • Europe
Register Now

Registration Options

Individual Registration

Proceed with Online Registration

Group Registration

Multi Registration Inquiry Form

left to register

Program Highlights

This training course will look at Extractables and Leachables from many different angles: definitions, regulations, material and polymer science, analytical E/L methodologies, safety assessments, and study design for different parenteral primary packaging systems and injection devices.

Overview

When making parenteral drug products, pharmaceutical companies are faced with the need to further investigate the materials that will be in contact with the drug product, either during manufacturing, intermediate storage, storage in its final packaging, or during the delivery of the drug to the patient. While historically, the potential safety issues were the main driver in these kinds of investigations, recently, quality issues (i.e. for biopharmaceuticals) have also become a concern.

This training course will look at Extractables & Leachables from many different angles, including, Definitions, Regulatory, Material & Polymer Science, Analytical E/L Methodologies, Safety Assessments, and Study Design for different parenteral primary packaging systems and injection devices.

A full session will be dedicated to an in-depth update on regulations, standards, and recommendations in this field (PQRI, USP, ISO 10993, BPOG).

Ask a Question

Agenda

  • Day 1
  • Day 2

  • Thursday, 25 April 2024

    09:00 I Introduction and Attendee Expectations

    09:15 I Introduction on Extractables & Leachables (E/L)

    • What is the importance of a good E/L-qualification?
    • Historical cases of leachables, impacting the quality or the safety of a drug product
    • Regulatory requirements (FDA, EMA…) for primary packaging

    10:30 I Coffee Break

    10:45 I Understanding the Materials, Used in the Manufacture of Pharmaceutical Containers & Closures

    • Types of polymers – examples in medical/pharmaceutical use
    • Understanding the composition of polymers: Intentionally added & Non-Intentionally added Compounds: Their function and origin
    • The issues with glass in parenteral applications

    11:30 I The Mechanism of Leaching

    • What are the physicochemical parameters to be considered when trying to understand polymer migration
    • How do leachables move through a polymer, the diffusion model
    • Special cases in migration

    12:00 I Lunch Break

    13:00 I How to Set-up Extractables & Leachables Studies Pharmaceutical Container Closure Systems
    Remote Presentation by Dennis Jenke

    • Selecting the right conditions for extraction
    • How to select the right compounds to monitor in a leachable study
    • Designing a leachable study

    14:45 I Coffee Break

    15:00 I Analytical Techniques to Perform Extractables & Leachables Research

    • The importance of sample preparation: the corner stone in E/L research
    • What are the target compounds for material research
    • How does a classification of these compounds assist in finding the right analytical technique
    • From basic “screening” methodologies to state-of-the-art equipment

    15:45 I How to Perform a Safety Evaluation – Risk Assessment on Extractables & Leachables

    • Toxicology 101
    • EMA Guideline on Genotoxic Impurities
    • ICH M7 (DNA reactive Impurities) and its suggested staged approach
    • The Threshold Concept of PQRI (OINDP and PDP/ODP)
    • Examples

    17:00 I End of Training Course Day 1

  • Friday, 26 April 2024

    08:30 I Recap Day 1

    08:45 I E/L Testing for a Small Volume Parenteral Container Closure systems

    • Glass Syringes: the issues with tungsten, glue residues and silicone oil and glass metals leaching
    • The Issue with rubbers: the plunger, the needle shield or the tip cap: different approaches needed?
    • The impact of secondary packaging – option or necessity?
    • Setting up extractable & leachable studies for a pre-filled Syringe
    • Biological Drug Products versus Small Molecule Drug Products
    • Primary packaging for the lyophilized drug product – modus of interaction with the DP
    • Critical aspects when designing leachable studies for lyophilized DP
    • Reactivity Of Leachables: concern for Lyophized drug Products
    • Integration of the administration procedure (e.g. IV-set, pump system) in leachables evaluation

    10:00 I Coffee Break

    10:15 I E/L Testing for Disposable and Single-Use Systems in Bioproduction

    • How to classify the risk of different single-use systems in the bioproduction process?
    • Understanding BPSA & BPOG recommendations, and how they can be implemented in the study design
    • Performing E/L studies on filters: potential approaches

    11:00 I Large Volume Parenterals

    • The challenge in E/L testing for LVP’s
    • Primary packaging for LVP’s – critical materials and components
    • Secondary packaging for LVP: critical points to consider

    11:30 I Lunch Break

    12:30 I Qualification of Injection Devices used for Parenteral Administrations

    • Short introduction into Medical Device Regulations (ISO 10993 series)
    • Difference in Approaches for Medical Devices, compared to Pharmaceutical Packaging
    • Considerations for Combination Products: how to proceed?

    14:00 I Coffee Break

    14:15 I Updates of E/L- Regulations, Standards and Recommendations

    • Pharma Packaging:
      o Final PQRI recommendations of the Parenteral Drug Product (DPD) Chemistry group
      o USP <661> & USP<665> chapters: where are we, where could it go to?
    • (Bio)Pharmaceutical Manufacturing
      o The BPOG protocol
    15:45 I Q&A

    16:00 I End of Training Course

Trainers

Piet Christiaens
Piet Christiaens
Nelson Labs NV
Bio
Piet Christiaens
Nelson Labs NV

Piet Christiaens received his Ph.D. from the Analytical Chemistry Department of the University of Leuven (Belgium) in 1991. From 1992 to 1997, he was Lab Manager in two Analytical Contract Laboratories. From 1997 to 2000, he worked as an independent consultant with Shell Chemical Company in Houston, TX (US), where he conducted research on a new hydrogenation catalyst system for Hydrogenated Triblock Co-polymers (Kraton Polymers).

From 2001 onwards, Dr. Christiaens holds the position of Scientific Director at Nelson Labs (formerly Toxikon Europe) where he developed analytical methods and protocols for both extractables and leachables studies for the Medical and Pharmaceutical Industries. In addition, he is also leading the R&D department at Nelson Labs, with a focus on understanding the interactions and chemistry of extractables and leachables and developing state-of-the-art analytical methodologies. In the last decade, Dr. Christiaens has been a speaker on the subject of “extractables and leachables” at over 150 Conferences, and since 2014, he has been engaged in the two-day Extractables and Leachables training courses that are hosted by PDA across the Globe. In his current role at Nelson Labs Europe, Dr. Christiaens supports the Strategy and Global Business Development for Extractables and Leachables Service Offerings for Pharmaceutical and Medical Applications.
Dennis Jenke
Dennis Jenke
Triad Scientific Solutions
Bio
Dennis Jenke
Triad Scientific Solutions

Dennis Jenke is the Chief Executive Scientist for Triad Scientific Solutions, a provider of science-based solutions to plastic/product compatibility challenges associated with packaging, manufacturing equipment and delivery devices in the pharmaceutical, cosmetic, food and related industries. He was a Distinguished Scientist at Baxter Healthcare Corporation where for more than three decades he lead a team whose primary responsibility includes the assessment of material/product compatibility, specifically with respect to establishing the suitability for use of packaging systems, manufacturing systems and administration devices for pharmaceutical products (for example, extractables/leachables and product ingredient binding).

He has published extensively in the areas of analytical chemistry, environmental science and material/solution compatibility and serves as an expert reviewer for numerous pharmaceutical and analytical journals. He is the author of the book Compatibility of Pharmaceutical Solutions and Contact Materials; Safety Considerations Associated with Extractables and Leachables and a contributing author to the Leachables and Extractables Handbook. Dennis Jenke is a member of numerous industry groups whose charter is to establish best demonstrated practices in the area of material/solution compatibility.

Additional Information

  • Learning Objectives

    Learning Objectives

    Upon completion of this training course, you will be able to:

    • Explain in detail the current regulatory requirements for container/closure qualification form an E/L perspective.
    • Explain the upcoming changes in regulations, standards and recommendations from PQRI, USP and BPOG and how these changes could impact a future evaluation of a pharmaceutical C/C-system.
    • Understand the materials of construction, including composition, of container closure systems, and how they could impact the safety and quality of a parenteral drug product.
    • Put together an evaluation program (review of provided documentation, analytical testing) of different types of parenteral drug product container/closure systems.
    • Perform a safety/risk assessment of analytical results, obtained after completion of an E/L study
  • Who Should Attend
    • Pharmaceutical Packaging and Device Engineers
    • Production Engineers, using SU systems
    • Regulatory Affairs Officers
    • Pharmaceutical R & D Managers
    • Analytical Chemists, working on E/L
    • Quality Assurance Officers

Got a Question? We have answers

Contact Us

Travel

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.

Ellehammersvej 20
Copenhagen, Denmark

How to Get Here

By Air

More information coming soon.

By Car

More information coming soon.

Other Options

More information coming soon.

Directions

Registration Fees

Regular Price
Registration Type Price
All Participants €2.090

* For this member type or discount, online registration is not available, please contact [email protected].

Group Registration Discount: Register 3 people from the same organization as a group (at the same time) for the event and receive the 4th registration free. Other discounts cannot be applied.

GENERAL TERMS AND CONDITIONS: PDA will send you a confirmation letter within one week of payment being received. You must have this confirmation letter to be considered enrolled in a PDA event. If you have submitted a purchase order or requested an invoice, please be advised that a credit card guarantee is needed. PDA reserves the right to modify the material or speakers/trainers without notice or to cancel an event. If an event is cancelled, registrants will be notified by PDA immediately and will receive a credit (registration fee paid). PDA will not be responsible for any costs incurred by registrants due to cancellation. Please note that the attendee list is shared with attendees, trainers, and exhibitors and may be used to follow up on specific areas of interest after the event. Video, photo, and audio recordings are prohibited at all PDA events.

CANCELLATION: If a cancellation request is received 30 days before the event, a credit (registration fee paid minus a 200.00 USD/EUR processing fee) will be given. No credits will be given for cancellation requests received less than 30 days before the event. Cancellation requests must be emailed to [email protected].

Sponsors

Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information

Exhibitors

Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information

Media Partners

Related Events

Related Events

Contact

Program Inquiries
Exhibition Inquiries
Training Course Inquiries

Tel: +1 (301) 656-5900
[email protected]

Tel: +49 (0) 30 43 655 08-10
[email protected]

Registration Customer Care

Tel: +1 (301) 656-5900 ext. 115
[email protected]

PDA Members Save Substantially